Population Health Blog

VUMC’s Office of Health Equity recently honored the Population Health Pharmacy Services team with a 2022-23 Health Equity Innovation Award.

All Americans ages 6 months and older are now eligible for a COVID-19 vaccination. VUMC research aided in the approval of these vaccines for younger children.

On June 20, the Today Show spotlighted a major new study from the Vanderbilt Memory and Alzheimer's Center (VMAC) tracking how good heart health may slow or even stop Alzheimer’s from developing in the brain.

To help employers prepare for fall vaccine season and catch up on important preventive care screenings, Vanderbilt Health Employer Solutions offers health fairs tailored to a workforce's health needs.

VHAN is coordinating its first Project ECHO session to equip pediatricians with the education and resources needed to better care for patients with pediatric depression.

Modeled after VHAN’s Pediatric Behavioral Consult Line, which has fielded more than 2,000 phone calls since launching in 2018, VHAN is launching a similar line later this year to assist clinicians with adults who need behavioral health support.

Happy start to summer! We hope everyone is staying safe from COVID-19, but if you do test positive, there is hopeful news about treatments.

The Vanderbilt Patient Reported Outcome Measures System (VPROMS) team recently accepted the 2022 Value-Based HealthCare Primary Care Award at a ceremony in the Netherlands.

Upcoming Well Moment webinars will focus on caregiver support and mental health support for pregnant and postpartum women.

If you test positive for COVID-19, Vanderbilt Health now has treatments that can help lower your risk of getting very sick, going to the hospital or dying. One such treatment is Paxlovid, an oral antiviral pill that can be taken at home.